• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在子宫平滑肌瘤中发现Med-12外显子2的多个突变。

Multiple Mutations in Exon-2 of Med-12 Identified in Uterine Leiomyomata.

作者信息

Firdaus Ruqia, Agrawal Prabha, Anagani Manjula, Vijayalakshmi Kodati, Hasan Qurratulain

机构信息

Department of Genetics and Molecular Medicine, Vasavi Medical and Research Center, Lakdi-ka-pool, Hyderabad, India.

Department of Biotechnology, Hyderabad Science Society, Hyderabad, India.

出版信息

J Reprod Infertil. 2021 Jul-Sep;22(3):201-209. doi: 10.18502/jri.v22i3.6720.

DOI:10.18502/jri.v22i3.6720
PMID:34900640
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8607871/
Abstract

BACKGROUND

Uterine leiomyomata (UL), commonly known as uterine fibroids, are benign smooth muscle tumors of the myometrium. They cause pelvic pain, abnormal uterine bleeding, and infertility in women of reproductive age. The ovarian hormone estrogen is the main stimulator for the fibroid growth. The etiology is not yet clearly understood; however, UL are believed to be monoclonal tumors arising from a common progenitor cell. Chromosomal cytogenetic abnormalities have been demonstrated in 40-50% of the fibroids. The most frequent tumor specific genetic alterations in UL were identified in exon-2 of Mediator Complex Subunit 12 (MED-12).

METHODS

In the present study, twenty-two multiple fibroids were evaluated both from the same uterus and from different uteri, of four women, for somatic mutations in hotspot region of MED-12. The tissue DNA of the UL's was isolated, amplified by PCR visualized on gel and sent for Sanger sequencing.

RESULTS

The results indicate several variants in exon-2 and flanking intronic regions, seven exonic variants and five intronic variants which provide evidence that multiple UL in the same uterus may not be clonal in origin.

CONCLUSION

This study indicates genetic heterogeneity. UL may not have a clonal origin, these exon-2 variants of MED-12 gene could be involved in UL progression.

摘要

背景

子宫平滑肌瘤(UL),通常被称为子宫肌瘤,是子宫肌层的良性平滑肌肿瘤。它们会导致育龄女性出现盆腔疼痛、异常子宫出血和不孕。卵巢激素雌激素是肌瘤生长的主要刺激因素。其病因尚未完全明确;然而,子宫平滑肌瘤被认为是由一个共同的祖细胞产生的单克隆肿瘤。在40%至50%的肌瘤中已证实存在染色体细胞遗传学异常。子宫平滑肌瘤中最常见的肿瘤特异性基因改变在中介体复合物亚基12(MED-12)的外显子2中被发现。

方法

在本研究中,对来自四名女性同一子宫和不同子宫的22个多发性肌瘤进行了MED-12热点区域体细胞突变的评估。分离子宫平滑肌瘤的组织DNA,通过聚合酶链反应(PCR)扩增,在凝胶上可视化,然后送去进行桑格测序。

结果

结果表明在外显子2和侧翼内含子区域有多个变异,七个外显子变异和五个内含子变异,这表明同一子宫内的多个子宫平滑肌瘤可能并非起源于克隆。

结论

本研究表明存在基因异质性。子宫平滑肌瘤可能并非起源于克隆,MED-12基因的这些外显子2变异可能与子宫平滑肌瘤的进展有关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b55/8607871/55f6d15cd663/JRI-22-201-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b55/8607871/aea4be9b2220/JRI-22-201-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b55/8607871/4f8fcb3aae71/JRI-22-201-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b55/8607871/55f6d15cd663/JRI-22-201-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b55/8607871/aea4be9b2220/JRI-22-201-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b55/8607871/4f8fcb3aae71/JRI-22-201-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b55/8607871/55f6d15cd663/JRI-22-201-g003.jpg

相似文献

1
Multiple Mutations in Exon-2 of Med-12 Identified in Uterine Leiomyomata.在子宫平滑肌瘤中发现Med-12外显子2的多个突变。
J Reprod Infertil. 2021 Jul-Sep;22(3):201-209. doi: 10.18502/jri.v22i3.6720.
2
The Mediator Complex Subunit 12 (MED-12) Gene and Uterine Fibroids: a Systematic Review.中介复合物亚基 12(MED-12)基因与子宫肌瘤:系统评价。
Reprod Sci. 2024 Feb;31(2):291-308. doi: 10.1007/s43032-023-01297-7. Epub 2023 Jul 29.
3
Exon 1 Mutational Screening in Iranian Patients with Uterine Leiomyoma.伊朗子宫平滑肌瘤患者外显子1的突变筛查
Rep Biochem Mol Biol. 2019 Apr;8(1):21-24.
4
Whole exome sequencing in a random sample of North American women with leiomyomas identifies MED12 mutations in majority of uterine leiomyomas.对北美的随机子宫肌瘤女性样本进行全外显子组测序,发现 MED12 突变存在于大多数子宫平滑肌瘤中。
PLoS One. 2012;7(3):e33251. doi: 10.1371/journal.pone.0033251. Epub 2012 Mar 12.
5
Expression profiling of uterine leiomyomata cytogenetic subgroups reveals distinct signatures in matched myometrium: transcriptional profilingof the t(12;14) and evidence in support of predisposing genetic heterogeneity.子宫肌瘤细胞遗传学亚组的表达谱分析显示匹配的子宫肌层中存在明显特征:t(12;14) 的转录谱分析和支持潜在遗传异质性的证据。
Hum Mol Genet. 2012 May 15;21(10):2312-29. doi: 10.1093/hmg/dds051. Epub 2012 Feb 17.
6
Recent Advances in Uterine Fibroid Etiology.子宫肌瘤病因学的最新进展
Semin Reprod Med. 2017 Mar;35(2):181-189. doi: 10.1055/s-0037-1599090. Epub 2017 Mar 9.
7
Genetic heterogeneity among uterine leiomyomata: insights into malignant progression.子宫平滑肌瘤的基因异质性:对恶性进展的见解
Hum Mol Genet. 2007 Apr 15;16 Spec No 1:R7-13. doi: 10.1093/hmg/ddm043.
8
Novel MED12 gene somatic mutations in women from the Southern United States with symptomatic uterine fibroids.美国南部有症状子宫肌瘤女性中的新型MED12基因体细胞突变。
Mol Genet Genomics. 2015 Apr;290(2):505-11. doi: 10.1007/s00438-014-0938-x. Epub 2014 Oct 18.
9
Epidemiological and genetic clues for molecular mechanisms involved in uterine leiomyoma development and growth.子宫平滑肌瘤发生和生长所涉及分子机制的流行病学及遗传学线索
Hum Reprod Update. 2015 Sep-Oct;21(5):593-615. doi: 10.1093/humupd/dmv030. Epub 2015 Jul 3.
10
Catechol-O-methyltransferase Val158Met polymorphism is associated with increased risk of multiple uterine leiomyomas either positive or negative for exon 2 mutations.儿茶酚-O-甲基转移酶Val158Met多态性与外显子2突变阳性或阴性的多发性子宫肌瘤风险增加有关。
J Clin Pathol. 2017 Mar;70(3):233-236. doi: 10.1136/jclinpath-2016-203976. Epub 2016 Aug 4.

引用本文的文献

1
Molecular Biology of Cancer-Interplay of Malignant Cells with Emerging Therapies.癌症分子生物学——恶性细胞与新兴疗法的相互作用
Int J Mol Sci. 2024 Dec 5;25(23):13090. doi: 10.3390/ijms252313090.
2
Analysis of Expression of the ANG1, CaSR and FAK Proteins in Uterine Fibroids.分析 ANG1、CaSR 和 FAK 蛋白在子宫肌瘤中的表达。
Int J Mol Sci. 2024 Jun 28;25(13):7164. doi: 10.3390/ijms25137164.

本文引用的文献

1
Expanded Somatic Mutation Spectrum of MED12 Gene in Uterine Leiomyomas of Saudi Arabian Women.沙特阿拉伯女性子宫平滑肌瘤中MED12基因体细胞突变谱的扩展
Front Genet. 2018 Dec 14;9:552. doi: 10.3389/fgene.2018.00552. eCollection 2018.
2
MED12 somatic mutations encompassing exon 2 associated with benign breast fibroadenomas and not breast carcinoma in Indian women.MED12 体细胞突变包含外显子 2 与印度女性良性乳腺纤维腺瘤相关,而不是乳腺癌。
J Cell Biochem. 2019 Jan;120(1):182-191. doi: 10.1002/jcb.27293. Epub 2018 Sep 19.
3
Silencing Med12 Gene Reduces Proliferation of Human Leiomyoma Cells Mediated via Wnt/β-Catenin Signaling Pathway.
沉默Med12基因可降低通过Wnt/β-连环蛋白信号通路介导的人平滑肌瘤细胞增殖。
Endocrinology. 2017 Mar 1;158(3):592-603. doi: 10.1210/en.2016-1097.
4
MED12 mutations in breast phyllodes tumors: evidence of temporal tumoral heterogeneity and identification of associated critical signaling pathways.乳腺叶状肿瘤中的MED12突变:肿瘤时间异质性的证据及相关关键信号通路的鉴定
Oncotarget. 2016 Dec 20;7(51):84428-84438. doi: 10.18632/oncotarget.12991.
5
Integrated data analysis reveals uterine leiomyoma subtypes with distinct driver pathways and biomarkers.综合数据分析揭示了具有不同驱动途径和生物标志物的子宫平滑肌瘤亚型。
Proc Natl Acad Sci U S A. 2016 Feb 2;113(5):1315-20. doi: 10.1073/pnas.1518752113. Epub 2016 Jan 19.
6
Med12 gain-of-function mutation causes leiomyomas and genomic instability.Med12功能获得性突变导致平滑肌瘤和基因组不稳定。
J Clin Invest. 2015 Aug 3;125(8):3280-4. doi: 10.1172/JCI81534. Epub 2015 Jul 20.
7
MED12 and uterine smooth muscle oncogenesis: State of the art and perspectives.MED12与子宫平滑肌肿瘤发生:现状与展望
Eur J Cancer. 2015 Aug;51(12):1603-10. doi: 10.1016/j.ejca.2015.04.023. Epub 2015 May 30.
8
Distribution of MED12 mutations in fibroadenomas and phyllodes tumors of the breast--implications for tumor biology and pathological diagnosis.乳腺纤维腺瘤和叶状肿瘤中MED12突变的分布——对肿瘤生物学和病理诊断的意义
Genes Chromosomes Cancer. 2015 Jul;54(7):444-52. doi: 10.1002/gcc.22256. Epub 2015 Apr 30.
9
MED12 somatic mutations in fibroadenomas and phyllodes tumours of the breast.乳腺纤维腺瘤和叶状肿瘤中的MED12体细胞突变。
Histopathology. 2015 Nov;67(5):719-29. doi: 10.1111/his.12712. Epub 2015 May 24.
10
Next-Gen Sequencing Exposes Frequent MED12 Mutations and Actionable Therapeutic Targets in Phyllodes Tumors.新一代测序揭示叶状肿瘤中频繁出现的MED12突变及可采取行动的治疗靶点。
Mol Cancer Res. 2015 Apr;13(4):613-9. doi: 10.1158/1541-7786.MCR-14-0578. Epub 2015 Jan 15.